Nova Eye Medical Ltd - Company Profile
Powered by 
All the data and insights you need on Nova Eye Medical Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Nova Eye Medical Ltd Strategy Report
- Understand Nova Eye Medical Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Nova Eye Medical Ltd (Nova Eye Medical), formerly Ellex Medical Lasers Ltd, is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company offers an array of proprietary medical devices and technologies 2RT, a laser technology for the treatment of diabetic retinopathy and age-related macular degeneration (AMD); iTrack, a surgical device and Molteno3, a glaucoma drainage device for treatment of glaucoma. Nova Eye Medical provides services directly to eye surgeons and to others, through a network of distribution partners. The company has operations in Europe, Asia-Pacific, Australia, and the Americas. Nova Eye Medical is headquartered in Kent Town, Australia.
Headquarters
Australia
Address
3-4 Second Avenue, Adelaide, South Australia, 5095
Website
www.ellex.com
Telephone
61 8 81045200
No of Employees
130
Industry
Medical Equipment
Ticker Symbol & Exchange
EYE (ASX)
Revenue (2023)
$11.9M
27.7%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
-104%
(2023 vs 2022)
Market Cap*
$39.3M
Net Profit Margin (2023)
XYZ
-59.8%
(2023 vs 2022)
* As of and is in US$
Nova Eye Medical Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| - | Glaucoma Surgery: | 2RT |
| iTrack | Mild-Moderate Glaucoma | iTrack |
| Technologies: | Advanced Glaucoma | MOLTENO3 |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Regulatory Approval | In April, the company was granted U.S. Food and Drug Administration (FDA) 510(k) clearance for its new canaloplasty device, iTrack Advance. |
| 2022 | New Products/Services | In April, the company announced the launch of Next Generation Canaloplasty Device for Glaucoma. |
| 2020 | Acquisitions/Mergers/Takeovers | In August, the company has acquired Molteno3 glaucoma drainage device from Molteno Ophthalmic Limited. |
Competitor Comparison
| Key Parameters | Nova Eye Medical Ltd | Topcon Corp | Iridex Corp | PolyNovo Ltd | CV Laser Pty Ltd |
|---|---|---|---|---|---|
| Headquarters | Australia | Japan | United States of America | Australia | Australia |
| City | Adelaide | Itabashi-Ku | Mountain View | Melbourne | Perth |
| State/Province | South Australia | Tokyo | California | Victoria | Western Australia |
| No. of Employees | 130 | 5,543 | 130 | 218 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Victor Previn | Chairman | Executive Board | 2005 | - |
| Tom Spurling | Director | Executive Board | 2021 | - |
| Simon Gray | Secretary | Senior Management | 2020 | - |
| Mike Southard | Director | Non Executive Board | 2018 | - |
| Rahmon Coupe | Director | Non Executive Board | 2013 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward